DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Fundamental Analysis & Valuation

NASDAQ:DHCNI • US25525P2065

Current stock price

17.9 USD
+0.22 (+1.24%)
At close:
17.9 USD
0 (0%)
After Hours:

This DHCNI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DHCNI Profitability Analysis

1.1 Basic Checks

  • In the past year DHCNI has reported negative net income.
  • DHCNI had a negative operating cash flow in the past year.
  • In the past 5 years DHCNI reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: DHCNI reported negative operating cash flow in multiple years.
DHCNI Yearly Net Income VS EBIT VS OCF VS FCFDHCNI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -6.56%, DHCNI is doing worse than 85.37% of the companies in the same industry.
  • DHCNI has a Return On Equity of -17.16%. This is amonst the worse of the industry: DHCNI underperforms 81.30% of its industry peers.
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROIC N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNI Yearly ROA, ROE, ROICDHCNI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10 -15

1.3 Margins

  • DHCNI has a Gross Margin of 18.11%. This is amonst the worse of the industry: DHCNI underperforms 92.68% of its industry peers.
  • DHCNI's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DHCNI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
DHCNI Yearly Profit, Operating, Gross MarginsDHCNI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DHCNI Health Analysis

2.1 Basic Checks

  • DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DHCNI has been increased compared to 1 year ago.
  • Compared to 5 years ago, DHCNI has more shares outstanding
  • Compared to 1 year ago, DHCNI has an improved debt to assets ratio.
DHCNI Yearly Shares OutstandingDHCNI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DHCNI Yearly Total Debt VS Total AssetsDHCNI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.34, we must say that DHCNI is in the distress zone and has some risk of bankruptcy.
  • DHCNI has a Altman-Z score of 0.34. This is comparable to the rest of the industry: DHCNI outperforms 42.28% of its industry peers.
  • DHCNI has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.44, DHCNI is in line with its industry, outperforming 44.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACCN/A
WACC8.6%
DHCNI Yearly LT Debt VS Equity VS FCFDHCNI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.56 indicates that DHCNI should not have too much problems paying its short term obligations.
  • DHCNI's Current ratio of 1.56 is amongst the best of the industry. DHCNI outperforms 82.11% of its industry peers.
  • DHCNI has a Quick Ratio of 1.56. This is a normal value and indicates that DHCNI is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.56, DHCNI belongs to the best of the industry, outperforming 82.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
DHCNI Yearly Current Assets VS Current LiabilitesDHCNI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DHCNI Growth Analysis

3.1 Past

  • DHCNI shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.76%.
  • DHCNI shows a small growth in Revenue. In the last year, the Revenue has grown by 2.84%.
  • The Revenue has been decreasing by -1.18% on average over the past years.
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.95% on average over the next years. This is a very strong growth
  • DHCNI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.03% yearly.
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DHCNI Yearly Revenue VS EstimatesDHCNI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DHCNI Yearly EPS VS EstimatesDHCNI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. DHCNI Valuation Analysis

4.1 Price/Earnings Ratio

  • DHCNI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNI Price Earnings VS Forward Price EarningsDHCNI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DHCNI is valued expensively inside the industry as 90.24% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.22
DHCNI Per share dataDHCNI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as DHCNI's earnings are expected to grow with 23.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.95%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. DHCNI Dividend Analysis

5.1 Amount

  • DHCNI has a yearly dividend return of 0.55%, which is pretty low.
  • Compared to an average industry Dividend Yield of 7.59, DHCNI's dividend is way lower than its industry peers. On top of this 92.68% of the companies listed in the same industry pay a better dividend than DHCNI!
  • Compared to an average S&P500 Dividend Yield of 1.82, DHCNI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

  • The dividend of DHCNI decreases each year by -25.96%.
  • DHCNI has been paying a dividend for over 5 years, so it has already some track record.
  • DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-25.96%
Div Incr Years0
Div Non Decr Years3
DHCNI Yearly Dividends per shareDHCNI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • DHCNI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.38%
EPS Next 2Y23.95%
EPS Next 3YN/A
DHCNI Yearly Income VS Free CF VS DividendDHCNI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

More info and screens

Find the best dividend stocksShow peers with best dividend

DHCNI Fundamentals: All Metrics, Ratios and Statistics

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (3/13/2026, 8:21:09 PM)

After market: 17.9 0 (0%)

17.9

+0.22 (+1.24%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners79.52%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.33B
Revenue(TTM)1.54B
Net Income(TTM)-285.89M
Analysts74.29
Price Target16.78 (-6.26%)
Short Float %0.02%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend0.04
Dividend Growth(5Y)-25.96%
DP-3.38%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-15
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.03%
Min EPS beat(2)-213.15%
Max EPS beat(2)49.08%
EPS beat(4)2
Avg EPS beat(4)-28.15%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)-9.87%
EPS beat(12)5
Avg EPS beat(12)-4.94%
EPS beat(16)5
Avg EPS beat(16)-13.8%
Revenue beat(2)1
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-4.35%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-4.35%
Max Revenue beat(4)0.67%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)5
Avg Revenue beat(16)-0.93%
PT rev (1m)-3.51%
PT rev (3m)-10.61%
EPS NQ rev (1m)-3.45%
EPS NQ rev (3m)-3.45%
EPS NY rev (1m)4.35%
EPS NY rev (3m)4.35%
Revenue NQ rev (1m)-2.43%
Revenue NQ rev (3m)-2.25%
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.82
P/FCF N/A
P/OCF N/A
P/B 2.6
P/tB 2.6
EV/EBITDA 28.22
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS6.35
BVpS6.88
TBVpS6.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.11%
FCFM N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA 10.3
Cap/Depr 56.06%
Cap/Sales 9.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 0.34
F-Score6
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)69.85%
Cap/Depr(5y)90%
Cap/Sales(3y)13.23%
Cap/Sales(5y)17.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y49.5%
EPS Next 2Y23.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%
Revenue Next Year2.55%
Revenue Next 2Y4.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1793.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.48%
OCF growth 3YN/A
OCF growth 5YN/A

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 / DHCNI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?

ChartMill assigns a fundamental rating of 2 / 10 to DHCNI.


What is the valuation status of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

ChartMill assigns a valuation rating of 1 / 10 to DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI). This can be considered as Overvalued.


How profitable is DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) has a profitability rating of 0 / 10.


How financially healthy is DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?

The financial health rating of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) is 3 / 10.


What is the expected EPS growth for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) is expected to grow by 49.5% in the next year.